126 related articles for article (PubMed ID: 28343159)
1. Half-and-half nails in a patient on antituberculosis treatment.
Chadwick A; Thwaites V; Holland M; Shahidi M
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28343159
[No Abstract] [Full Text] [Related]
2. [Development of eosinophilic pneumonia in a patient with latent tuberculosis infection resulting from isoniazid].
Umeda N; Inada Y; Mamoto T
Kekkaku; 2014 Oct; 89(10):777-80. PubMed ID: 25730952
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for isoniazid hepatotoxicity in children with latent TB and TB: difference from adults.
Devrim I; Olukman O; Can D; Dizdarer C
Chest; 2010 Mar; 137(3):737-8. PubMed ID: 20202962
[No Abstract] [Full Text] [Related]
4. Acute groove pancreatitis due to isoniazid.
Yi PH; Veltre DR; Kuttab JS; Rangan V; Norton L
Neth J Med; 2013 Mar; 71(2):104. PubMed ID: 23462062
[No Abstract] [Full Text] [Related]
5. Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious?
Sánchez-Moya AI; Dauden E
Int J Dermatol; 2014 Mar; 53(3):e211-2. PubMed ID: 23786208
[No Abstract] [Full Text] [Related]
6. Isoniazid-induced acute liver failure during preventive therapy for latent tuberculosis infection.
Miyazawa S; Matsuoka S; Hamana S; Nagai S; Nakamura H; Nirei K; Moriyama M
Intern Med; 2015; 54(6):591-5. PubMed ID: 25786447
[TBL] [Abstract][Full Text] [Related]
7. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
Duarte R; Carvalho A; Correia A
Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
[No Abstract] [Full Text] [Related]
8. Systemic necrotizing vasculitis induced by isoniazid.
Tan CD; Smith A; Rodriguez ER
Cardiovasc Pathol; 2014; 23(3):181-2. PubMed ID: 24508138
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid toxicity in a 5-year-old boy.
Science M; Ito S; Kitai I
CMAJ; 2013 Jul; 185(10):894-6. PubMed ID: 23670154
[No Abstract] [Full Text] [Related]
10. [Lichenoid drug eruption with antituberculosis drugs associated with an anonychia].
BayBay H; Saàdani C; Elloudi S; Douhi Z; Rimani M; Achour S; Mernissi FZ
Ann Dermatol Venereol; 2020; 147(6-7):456-460. PubMed ID: 32229034
[TBL] [Abstract][Full Text] [Related]
11. Question 1: what are the options for treating latent TB infection in children?
Gwee A; Coghlan B; Curtis N
Arch Dis Child; 2013 Jun; 98(6):468-74. PubMed ID: 23661667
[No Abstract] [Full Text] [Related]
12. Tuberculosis: which drug regimen and when.
Hall J; Elliott C
J Fam Pract; 2015 Jan; 64(1):27-33. PubMed ID: 25574509
[TBL] [Abstract][Full Text] [Related]
13. Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just?
Kyanko KA; Tsay JC; Yun K; Parent B
AMA J Ethics; 2016 Mar; 18(3):311-8. PubMed ID: 27003003
[No Abstract] [Full Text] [Related]
14. [Isoniazid-inducedtoxic hepatitis].
Kristensen KL; Nordholm AC; Clausen MR; Katzenstein TL
Ugeskr Laeger; 2021 Feb; 183(6):. PubMed ID: 33570026
[TBL] [
